您的位置: 首页 > 农业专利 > 详情页

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
专利权人:
Universite De Montreal;BRISTOL-MYERS SQUIBB COMPANY
发明人:
Jacques Banville,Roger Rémillard,Edward H. Ruediger,Daniel H. Deon,Marc Gagnon,Laurence Dubé,Julia Guy,Eldon Scott Priestley,Shoshana L. Posy,Brad D. Maxwell,Pancras C. Wong,R. Michael Lawrence,Michae
申请号:
US14396771
公开号:
US09688695B2
申请日:
2013.04.24
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention provides thiazole compounds of Formula I wherein W, Y, R0, R2, R4, R5, R6, R7, X1, X2, X3 and X4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充